Filing Details
- Accession Number:
- 0000019617-17-000417
- Form Type:
- 13G Filing
- Publication Date:
- 2017-05-19 13:56:53
- Filed By:
- Jpmorgan Chase & Co
- Company:
- Reva Medical Inc. (ASX:RVA.AX)
- Filing Date:
- 2017-05-19
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| JPMorgan Chase Co | 3,320,201 | 0 | 3,320,201 | 0 | 3,320,201 | 7.5% |
| J.P. Morgan GT Corp | 3,320,201 | 0 | 3,320,201 | 0 | 3,320,201 | 7.5% |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(c)
REVA MEDICAL, INC.
( NAME OF ISSUER )
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
U8000C103
(CUSIP Number)
May 02, 2017
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
|
| Rule 13d-1 (b) | |
|
|
| X Rule 13d-1 (c) | |
|
|
| Rule 13d-1 (d) | |
| CUSIP No. U8000C103 | 13G |
| 1. | Names of reporting persons | JPMorgan Chase & Co. | |
|
| I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) | 13-2624428 | |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* | (a) |
|
|
| (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION |
|
| Delaware |
| NUMBER OF | 5. | SOLE VOTING POWER | 3,320,201 |
| SHARES |
|
|
|
| BENEFICIALLY | 6. | SHARED VOTING POWER | 0 |
| OWNED BY |
|
|
|
| EACH | 7. | SOLE DISPOSITIVE POWER | 3,320,201 |
| REPORTING |
|
|
|
| PERSON WITH | 8. | SHARED DISPOSITIVE POWER | 0 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
| 3,320,201 |
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES |
|
|
| CERTAIN SHARES |
|
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
| 7.5% |
| 12. | TYPE OF REPORTING PERSON* | HC |
| 1. | Names of reporting persons | J.P. Morgan GT Corp | |
|
| I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) | 00-0000000 | |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* | (a) |
|
|
| (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION |
|
| Delaware |
| NUMBER OF | 5. | SOLE VOTING POWER | 3,320,201 |
| SHARES |
|
|
|
| BENEFICIALLY | 6. | SHARED VOTING POWER | 0 |
| OWNED BY |
|
|
|
| EACH | 7. | SOLE DISPOSITIVE POWER | 3,320,201 |
| REPORTING |
|
|
|
| PERSON WITH | 8. | SHARED DISPOSITIVE POWER | 0 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
| 3,320,201 |
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES |
|
|
| CERTAIN SHARES |
|
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
| 7.5% |
| 12. | TYPE OF REPORTING PERSON* | CO |
| Item 1(a). | Name of Issuer: |
|
| REVA MEDICAL, INC. |
| Item 1(b). | Address of Issuer's Principal Executive Offices: |
|
| 5751 Copley Drive San Diego, CA 92111 |
|
|
|
| Item 2(a). | Name of Person Filing: |
|
| (1)JPMorgan Chase & Co. (2) J.P. Morgan GT Corp |
| Item 2(b). | Address of Principal Business Office or, if None, Residence: |
|
| (1) 270 PARK AVE |
|
| NEW YORK, NY 10017 (2) 270 Park Avenue |
|
| NEW YORK, NY 10017 |
| Item 2(c). | Citizenship |
|
| (1) Delaware (2) Delaware |
| Item 2(d). | Title of Class of Securities: |
|
| Common Stock, $0.0001 par value per share |
|
| Unless otherwise noted, security being reported is common stock |
| Item 2(e). | CUSIP Number: | U8000C103 |
| Item 3 | If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) |
| Or (c), Check Whether the Person Filing is a : |
|
| (a) | Broker or dealer registered under Section 15 of the Exchange Act; | |
| (b) | Bank as defined in Section 3(a)(6) of the Exchange Act; | ||
| (c) | Insurance company as defined in Section 3(a)(19) of the | ||
| Exchange Act; | |||
| (d) | Investment company registered under Section 8 of the Investment | ||
| Company Act; | |||
| (e) | An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); | ||
| (f) | An employee benefit plan or endowment fund in accordance with | ||
| Rule 13d-1(b)(1)(ii)(F); | |||
| (g) | A parent holding company or control person in accordance with | ||
| Rule 13d-1(b)(1)(ii)(G); | |||
| (h) | A savings association as defined in Section 3(b) of the Federal | ||
| Deposit Insurance Act; | |||
| (i) | A church plan that is excluded from the definition of an | ||
| Investment company under Section 3(c)(14) of the Investment | |||
| Company act; | |||
| (j) | Group, in accordance with Rule 13d-1(b)(1)(ii)(J). |
| If this statement is filed pursuant to Rule 13d-1(b), check this box. |
| Item 4. | Ownership |
|
| The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page(s) to this Schedule 13G. | ||||||||||
| Item 5. | Ownership of Five Percent or Less of a Class. NOT APPLICABLE |
|
| If this statement is being filed to report the fact that as of the date |
|
| hereof the reporting person has ceased to be the beneficial owner of |
|
| more than five percent of the class of securities, check |
|
| the following. ( ) |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the |
|
| Security being reported on by the Parent Holding Company. |
| This notice is filed on behalf of JPMorgan Chase & Co. and its wholly | |
| owned Subsidiary (ies), | |
| J.P. Morgan GT Corporation | |
| Item 8. | Identification and Classification of Members of the Group. |
|
| Not Applicable |
| Item 9. | Notice of Dissolution of Group. |
|
| Not Applicable |
| Item 10. | Certifications |
| By signing below I certify that, to the best of my knowledge and belief, | |
| the securities referred to above were acquired and are held in the | |
| ordinary course of business and were not acquired and are not held | |
| for the purpose of or with the effect of changing or influencing | |
| the control of the issuer of the securities and were not acquired | |
| and are not held in connection with or as a participant in any | |
| transaction having that purpose or effect. |
| SIGNATURE |
| After reasonable inquiry and to the best of my knowledge and belief, I certify that the |
| information set forth in this statement is true, complete and correct. |
| Dated: May 19, 2017 | JPMorgan Chase & Co. |
|
| By: /s/ Michael T. Lees |
|
| -------------------------------------- |
|
| Michael T. Lees |
|
| Compliance |
| The original statement shall be signed by each person on whose behalf the statement |
| is filed or his authorized representative. If the statement is signed on behalf of |
| a person by his authorized representative (other than an executive officer or general |
| partner of the filing person), evidence of the representative's authority to sign on |
| behalf of such person shall be filed with the statement, provided, however, that a |
| power of attorney for this purpose which is already on file with the commission may |
| be incorporated by reference. The name and any title of each person who signs the |
| the statement shall be typed or printed beneath his signature. |